The Affordable Care Act: How Provider Organizations Can Succeed Under Health Reform

The Affordable Care Act has triggered many changes in the health care delivery system. Learn about the health reform-inspired approaches to redesigning care that work (or don't work) for management of chronic conditions, including diabetes — from ACOs to bundled payments to patient centered medical homes.

I recently had the opportunity to present to the domestic affiliates of Joslin Diabetes Center on this topic.

Here's the full blurb for this webinar:

The Affordable Care Act has far-reaching effects on the financing and delivery of health care services in this country. Most of the Act has been phased in already; there are a few things that will be taking effect over the next year or so. One core element of the Act is the Medicare Shared Savings Program, which produced the Accountable Care Organization. ACOs exist in the commercial insurance world as well, as part of the broader trend towards value-based payment. It is critical that Joslin affiliates be comfortable with value-based payment methodologies in order to respond to the imperatives in the marketplace to enter into value-based agreements with payors for the delivery of services to persons with diabetes.
 
In this session we will discuss the evolution of value-based payment systems in health care over time, the current lay of the land, the need to redesign care delivery and coordination in order to succeed in a changed marketplace, and some examples of approaches to payment redesign and to care redesign taken by some leading clinical organizations that may be incorporated into your organization's operations.

I invite you to listen in should you be interested (and have 40 minutes). Just click the link or embed up at the top of this post, grab a cup of coffee, put up your feet, and check it out.

To listen to or read the interviews with the primary care innovators mentioned in this presentation, check out the interviews with leaders of organizations providing primary care on steroids.

David Harlow
The Harlow Group LLC
Health Care Law and Consulting